Physician profile
Michelle Master
NPI 1609166339
$557.50
in general payments reported to CMS, 2019-2025
11 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $438 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $174.01 | 2024 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $108.70 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Shield Therapeutics INC | $60.86 | 2024 | |
| Lucid Diagnostics INC. | $34.89 | 2024-2025 | |
| Becton, Dickinson and Company | $32.75 | 2024-2025 | Bd Onclarity |
| Merck Sharp & Dohme LLC | $32.00 | 2024 | Gardasil, Gardasil 9, Capvaxive |
| Kowa Pharmaceuticals America, INC. | $31.52 | 2024-2025 | Zoryve |
| Exact Sciences Corporation | $25.52 | 2025 | Cologuard Collection Kit |
| Medline Industries LP | $20.33 | 2025 | |
| Phathom Pharmaceuticals, INC. | $19.26 | 2024 | Voquezna |
| Pfizer INC. | $17.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Master listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.